Streamlining Affinity Analysis for Accelerated Drug Discovery

Antibody and protein therapeutics are a major focus in drug discovery pipelines today. Hence, streamlining affinity analysis workflows are key to staying ahead of the competition and accelerating drugs to the clinic. The increasing complexity of novel biotherapeutics can present challenges to drug development and manufacturing. Notably, most analytical techniques cannot measure sequential binding events to evaluate a molecule’s specificity and affinity for multiple targets. This whitepaper highlights the features and capabilities of a novel system for streamlining affinity analysis for rapid lead molecule screening. Download this whitepaper to discover: The right characterization techniques for your analysis workflows Methods for rapid large-scale compound screening directly in complex matrices How bio-layer interferometry can eliminate common challenges in drug candidate characterization